Linsitinib is a small-molecule dual insulin-like growth factor-1 receptor (IGF-IR) and insulin receptor (IR) kinase inhibitor. IGF-I receptor (IGF-IR) has been implicated in the promotion of tumorigenesis, metastasis and resistance to cancer therapies and thus Linsitinib may be a useful anticancer agent. Appearance: White to off-white crystalline solid Purity: 99% (HPLC, TLC) Solubility: DMSO, 50mg/ml Melting Point: 233-237C
Molecular Weight:
421.49
Purity:
99% (HPLC, TLC)
Form:
White to off-white crystalline solid
CAS Number:
[867160-71-2]
* VAT and and shipping costs not included. Errors and price changes excepted